English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 849159      Online Users : 1614
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Patents [0/42]
    Periodical Articles [141/141]
    Conference Papers/Meeting Abstract [30/48]

    Community Statistics


    Item counts issued in 3 years:13(5.63%)
    Items With Fulltext:171(74.03%)

    Download counts of the item
    Download times greater than 0:171(100.00%)
    Download times greater than 100:167(97.66%)
    Total Bitstream Download Counts:101477(1.89%)

    Last Update: 2024-11-28 13:45

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 201-225 of 231. (10 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2006-06-15 Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies Journal of Medicinal Chemistry. 2006 Jun;49(12):3485-3495.
    2006-06-15 Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors Bioorganic and Medicinal Chemistry Letters. 2006 Jun;16(12):3268-3272.
    2006-05-04 Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities Journal of Medicinal Chemistry. 2006 May;49(9):2703-2712.
    2006-05 Antitubulin agents for the treatment of cancer - a medicinal chemistry update Expert Opinion on Therapeutic Patents. 2006 May;16(5):647-691.
    2006-02-09 Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies Journal of Medicinal Chemistry. 2006 Feb;49(3):1212-1216.
    2006-01-12 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV Journal of Medicinal Chemistry. 2006 Jan;49(1):373-380.
    2006-01-01 Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system Bioorganic and Medicinal Chemistry. 2006 Jan 1;14(1):83-91.
    2005-12-29 Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208.
    2005-08-23 Indole compounds US6933316B2/2005-08-23
    2005-05 Shear stress inhibits smooth muscle cell-induced inflammatory gene expression in endothelial cells - Role of NF-kappa B Arteriosclerosis, Thrombosis, and Vascular Biology. 2005 May;25(5):963-969.
    2005-05 Pharmaceutical design of antimitotic agents based on combretastatins Current Pharmaceutical Design. 2005 May;11(13):1655-1677.
    2005-03 Promazine analogues as potential anti SARS-CoV drugs Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U168.
    2005-03 Design, synthesis and sar of indole-based PPAR agonists Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.
    2005-03 Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.
    2005 Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3) Evidence-based Complementary and Alternative Medicine. 2005;2:209-215.
    2004-09-10 Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV FEBS Letters. 2004 Sep;574(1-3):116-120.
    2004-09 Drug design of BPR0L075 as an anticancer agent World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203.
    2004-08-22 Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents Abstracts of Papers - American Chemical Society. 2004 Aug 22;228:U924.
    2004-08-12 Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents Journal of Medicinal Chemistry. 2004 Aug;47(17):4247-4257.
    2004-07-15 A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells Biochemical Pharmacology. 2004 Jul;68(2):293-303.
    2004-07-01 BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo Cancer Research. 2004 Jul;64(13):4621-4628.
    2004-07 Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide Antimicrobial Agents and Chemotherapy. 2004 Jul;48(7):2693-2696.
    2004-07 Drug design for BPR0L075 as an anticancer agent Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul.
    2004-05-20 Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents Journal of Medicinal Chemistry. 2004 May;47(11):2897-2905.
    2003-12-01 Substituent effects on di-pi-methane and aza-di-pi-methane rearrangements of dibenzo[f,h]quinoxalinobarrelenes Tetrahedron Letters. 2003 Dec;44(49):8761-8764.

    Showing items 201-225 of 231. (10 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback